Middle Meningeal Artery Embolization for the Treatment of Chronic Subdural Hematomas—a German Nationwide Multi-center Study On 718 Embolizations
Rattachement africain : de. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: Embolization of the middle meningeal artery (EMMA) is a promising novel technique for the treatment of patients with chronic subdural hematomas (cSDH). METHODS: After a nationwide query in Germany, patients with cSDH, treated with EMMA were retrospectively analyzed. Patient and cSDH characteristics, procedural parameters, complications, and rates of treatment failure (TF; residual cSDH > 10 mm, cSDH progression or requirement of rescue surgery) were investigated. TF rates were compared between first-time treatments and treatments of recurrent cSDH, patients receiving embolization and surgery and those being embolized only, different types of embolic agents (particles vs. liquid agents) and between patients with and without antithrombotic medication. RESULTS: 718 EMMAs (420 unilateral, 149 bilateral) were performed in 569 patients in 30 German neurovascular centers. 57.1% were first-time treatments and 42.9% were treatments of recurrent cSDHs. The most frequently used embolic agents were particles (56.2%), followed by copolymer-based liquid embolic agents (19.6%). The rate of symptomatic procedure-related complications was 2.5%. After a mean follow-up of 6.5 months, TF was observed in 16.2% across all treatments and was more frequent after the treatment of recurrent cSDHs (19.8% vs. 13.5%, p = 0.045) and in patients taking antithrombotic drugs (17.7% vs. 11.5%; p = 0.044). TF was not significantly different regarding the type of embolic agent or additional surgery. CONCLUSIONS: In this nationwide multi-center study, EMMA was associated with favorable clinical outcomes and a low complication rate, supporting the results of recently published randomized controlled trials. TF was more frequent in recurrent cSDH treatments and in patients taking antithrombotic drugs.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Middle Meningeal Artery Embolization for the Treatment of Chronic Subdural Hematomas—a German Nationwide Multi-center Study On 718 Embolizations
- Date Crossref
- 18/08/2025
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Heidelberg University pays non établi dans la noticeUniversité ou école supérieure
-
University Hospital Heidelberg Department of Neuroradiology pays non établi dans la noticeÉtablissement de santé
-
University Hospital Augsburg Diagnostic and Interventional Neuroradiology pays non établi dans la noticeÉtablissement de santé
-
Schön Klinik Vogtareuth pays non établi dans la noticeÉtablissement de santé
-
Goethe University Frankfurt pays non établi dans la noticeUniversité ou école supérieure
-
Klinikum Darmstadt pays non établi dans la noticeÉtablissement de santé
-
Helios Hospital Berlin-Buch pays non établi dans la noticeÉtablissement de santé
-
Klinikum Fulda pays non établi dans la noticeÉtablissement de santé
-
Paracelsus Medizinische Privatuniversität pays non établi dans la noticeUniversité ou école supérieure
-
Klinikum Frankfurt Höchst pays non établi dans la noticeÉtablissement de santé
-
Alfried Krupp Hospital pays non établi dans la noticeÉtablissement de santé
-
Johanna-Etienne-Krankenhaus pays non établi dans la noticeÉtablissement de santé
Heidelberg University, Department of Neuroradiology — University Hospital Heidelberg et Diagnostic and Interventional Neuroradiology — University Hospital Augsburg, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.